BioLife Solutions, Inc. (BLFS) Balance Sheet

NASDAQ: BLFSAssets, liabilities, debt and equity over 10 years.

BLFS balance sheet, 2025

December 31, 2025 · U.S. dollars

$405.9M assets = $34.0M liabilities + $371.9M equity

What it owns$405.9MCash & ST investments: $88.9M (21.9%)Cash & ST investments$88.9M · 22%Receivables: $8.0M (2.0%)Inventory: $30.2M (7.4%)Inventory $30.2MOther current: $9.5M (2.3%)PP&E: $22.2M (5.5%)Goodwill & intangibles: $212.8M (52.4%)Goodwill & intangibles$212.8M · 52%LT investments: $31.2M (7.7%)LT investments $31.2MOther non-current: $3.0M (0.8%)=How it is financed$405.9MCurrent liabilities: $23.0M (5.7%)Other LT liabilities: $11.0M (2.7%)Shareholders’ equity: $371.9M (91.6%)Shareholders’ equity$371.9M · 92%

Both columns are drawn to the same scale: what BLFS owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BLFS financial health

Current ratio5.94
Comfortable · current assets cover current liabilities 5.94×
Debt / equity0.05
Low leverage · $0.05 of debt for each $1 of equity
Equity / assets91.6%
Equity-funded · of assets funded by shareholders
Cash / debt496.9%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles52.4%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BLFS balance sheet trends, 2016–2025

BioLife Solutions, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$7.9M2016$405.9M2025+54.9%/yr
Total liabilities$4.8M2016$34.0M2025+24.4%/yr
Shareholders’ equity$3.2M2016$371.9M2025+69.8%/yr
Cash & short-term investments$1.4M2016$88.9M2025+58.5%/yr
Total debt$5.7M2016$17.9M2025+13.6%/yr
Net cash (debt)−$4.3M2016$71.0M2025+$75.3M
Working capital$3.5M2016$113.6M2025+$110.1M
Book value per share$0.252016$7.642025+46.2%/yr
Current ratio4.0820165.942025+1.86
Debt / equity1.8020160.052025−1.75
Shares outstanding12.6M201648.6M2025+16.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BLFS assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BLFS liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BLFS debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BLFS balance sheet

BioLife Solutions, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$88.9M$104.6M$44.2M$62.7M$69.9M$90.5M$6.4M$30.7M$6.7M$1.4M
Cash & equivalents$33.0M$95.4M$27.9M$19.4M$69.9M$90.5M$6.4M$30.7M$6.7M$1.4M
Short-term investments$55.9M$9.2M$16.3M$43.3M$0$5.9M——$0$1.7M
Receivables$8.0M$9.2M$18.7M$33.9M$23.2M$8.0M$5.3M$3.0M$1.0M$1.2M
Inventory$30.2M$29.0M$43.5M$34.9M$28.3M$11.6M$11.1M$3.5M$1.8M$1.8M
Other current assets$9.5M$6.0M$14.3M$6.9M$4.7M$4.6M$1.3M$353,000$400,000$270,354
Total current assets$136.6M$148.8M$120.6M$138.5M$126.1M$114.7M$24.2M$37.6M$9.9M$4.6M
Property, plant & equipment (net)$22.2M$16.8M$32.6M$39.2M$36.8M$19.8M$6.6M$1.3M$1.1M$1.2M
Goodwill & intangible assets$212.8M$221.9M$245.9M$256.8M$376.9M$89.5M$55.6M$0$0$3.9M
Long-term investments$31.2M$5.6M$5.6M$6.4M$4.4M$5.9M$2.5M$6.5M$1.1M$2.1M
Other non-current assets$3.0M$6.5M$8.0M$9.3M$10.1M$4.9M$4.1M$36,000$35,844$0
Total assets$405.9M$399.5M$412.7M$450.2M$554.3M$234.8M$93.0M$45.5M$12.1M$7.9M
Liabilities
Accounts payable$1.5M$3.6M$6.9M$15.4M$14.9M$3.7M$3.1M$720,000$691,000$710,719
Short-term debt$7.2M$12.5M$7.6M$4.8M$3.8M$1.7M$817,000——$2.8M
Deferred revenue$195,000$103,000$661,000$548,000$814,000$931,000$324,000$130,000$130,000—
Total current liabilities$23.0M$32.7M$42.2M$44.6M$42.7M$15.6M$7.7M$1.9M$1.5M$1.1M
Long-term debt$0$5.0M$18.3M$23.8M$6.4M$655,000$0$0$0$2.8M
Lease obligations$12.9M$14.2M$17.5M$18.1M$19.7M$9.9M$1.4M———
Other long-term liabilities$11.0M$12.8M$14.6M$17.7M$27.2M$13.4M$41.7M$28.9M$538,000$784,000
Total liabilities$34.0M$50.6M$75.1M$86.0M$76.2M$29.6M$49.4M$30.8M$2.1M$4.8M
Shareholders' equity
Common stock & paid-in capital$48,000$47,000$45,000$43,000$42,000$33,000$21,000$19,000$72.8M$74.4M
Retained earnings (deficit)−$339.7M−$335.1M−$313.3M−$246.9M−$107.1M−$97.4M−$100.1M−$98.4M−$74.0M−$71.2M
Treasury stock————————$0$0
Accumulated other comprehensive income$132,000$24,000−$345,000−$679,000−$282,000$0$0−$2.3M−$2.0M−$1.7M
Minority interest————————$0$0
Total shareholders' equity$371.9M$348.9M$337.7M$364.2M$478.0M$205.2M$83.0M$14.6M$10.1M$3.2M
Key figures
Total debt$17.9M$30.2M$33.8M$43.7M$26.9M$11.2M$1.4M——$5.7M
Net cash (debt)$71.0M$74.4M$10.4M$19.0M$43.0M$79.3M$5.1M——−$4.3M
Working capital$113.6M$116.0M$78.4M$93.9M$83.4M$99.1M$16.5M$35.6M$8.4M$3.5M
Tangible book value$159.0M$127.0M$91.8M$107.4M$101.2M$115.7M$27.4M$14.6M$10.1M−$748,120
Book value per share$7.64$7.57$7.72$8.57$12.42$7.52$4.27$0.90$0.76$0.25
Shares outstanding48.6M46.1M43.7M42.5M38.5M27.3M19.5M16.3M13.3M12.6M
Current ratio5.944.542.863.112.957.373.1519.376.564.08
Quick ratio4.223.481.492.172.186.321.5417.385.082.29
Debt / equity0.050.090.100.120.060.050.02——1.80
Equity / assets91.6%87.3%81.8%80.9%86.2%87.4%89.3%32.2%83.1%39.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.

BLFS financial position

At the end of fiscal 2025 (December 31, 2025), BioLife Solutions had total assets of $405.9 million (up 1.6% from a year earlier), total liabilities of $34.0 million and shareholders' equity of $371.9 million. It held $88.9 million in cash and short-term investments against $17.9 million of debt, a net cash position of $71.0 million. Its current ratio was 5.94. In the latest quarter (ended June 30, 2026) total assets were $447.5 million and equity $420.0 million.

Related: BLFS income statement, BLFS cash flow statement, BLFS key metrics. See the BLFS stock overview for the latest quote and news.

BLFS balance sheet FAQ

What are BioLife Solutions's total assets?

BioLife Solutions reported total assets of $405.9 million at the end of fiscal 2025 (December 31, 2025), compared with $399.5 million a year earlier.

How much debt does BioLife Solutions have?

BioLife Solutions had $17.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.05.

How much cash does BioLife Solutions have?

BioLife Solutions held $88.9 million in cash and short-term investments at the end of fiscal 2025; with $17.9 million of debt that is net cash of $71.0 million.

What is BioLife Solutions's book value?

BioLife Solutions's shareholders' equity (book value) was $371.9 million at the end of fiscal 2025, or $7.64 per share.

What is BioLife Solutions's current ratio?

BioLife Solutions had current assets of $136.6 million and current liabilities of $23.0 million, a current ratio of 5.94 (it can cover its short-term obligations).

How much goodwill does BioLife Solutions have?

BioLife Solutions carried $212.8 million of goodwill and intangible assets, 52.4% of total assets, at the end of fiscal 2025.

Medical Instruments & Supplies: balance sheet